Sounds like a pretty cool event from my friends at Technion!
Several professional titles grace Gad Rennert’s signature, giving him charge of Clalit’s National Cancer Control Center and Personalized Medicine Program, and its Breast and Colorectal Cancer Detection Program. Clalit is Israel’s largest health provider. He is also a Technion professor at The Ruth and Bruce Rappaport Faculty of Medicine and chairman of the Department of Community Medicine and Epidemiology at the Technion-affiliated Carmel Medical Center.
Dr. Rennert wears many hats, but his interests are mostly focused on cancer genetics. Renowned for his large-scale studies of breast cancer and BRCA gene mutations in Israeli women, he has launched the First International Conference on “Founder Populations and their Contribution to our Understanding of Biology and History – Lessons from the Jewish Genome” (July 10-13, Haifa, Israel). We recently had the opportunity to interview him about this most exciting initiative.
What makes this gathering the first of its kind?
Dr. Gad Rennert
View original post 676 more words